Skip to content
WeighLab

SkinnyRx vs ReadyRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

SkinnyRx

Affiliate partner

Shoppers who want a cheap first month to see how they tolerate a GLP-1, and who will budget for the price from month two.

Semaglutide / month
$249/moMonth to month after a $99 first month ($199/mo on a 12-month plan)
Tirzepatide / month
$299/moMonth to month after a $99 first month ($225/mo on a 12-month plan)
Index 74/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check SkinnyRx pricing Read review

ReadyRx

Provider comparison

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Semaglutide / month
$249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month
$315/moStanding one-month compounded plan; $295 first month with current public offer
Index 76/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check ReadyRx pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

ReadyRx has the higher Cost-Efficiency Index: 76/100 versus 74/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

SkinnyRx
Most states
ReadyRx
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

SkinnyRx

ReadyRx

Semaglutide / month
SkinnyRx: $249/moMonth to month after a $99 first month ($199/mo on a 12-month plan)
ReadyRx: $249/moStanding one-month compounded plan; $229 first month with current public offer
Tirzepatide / month
SkinnyRx: $299/moMonth to month after a $99 first month ($225/mo on a 12-month plan)
ReadyRx: $315/moStanding one-month compounded plan; $295 first month with current public offer
Semaglutide / year (modeled)
SkinnyRx: $2,988
ReadyRx: $2,988
Tirzepatide / year (modeled)
SkinnyRx: $3,588
ReadyRx: $3,780
State availability
SkinnyRx: Most states
ReadyRx: All 50 states
Oral / sublingual option listed
SkinnyRx: Yes
ReadyRx: Not listed
Brand-name access listed
SkinnyRx: Not confirmed
ReadyRx: Yes
Provider facts checked
SkinnyRx: October 2026
ReadyRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

SkinnyRx

Shoppers who want a cheap first month to see how they tolerate a GLP-1, and who will budget for the price from month two.

Reasons to consider it

  • The first month of either injection is $99, so trying the medication costs little
  • Prepaid plans lower the price: semaglutide renews at $225 a month on four months, $215 on six and $199 on twelve
  • Both compounded molecules come as a weekly injection or a daily tablet

What to weigh up

  • From month two the injection is $249 for semaglutide or $299 for tirzepatide, well above the $99 you see first
  • An FDA warning letter is on public record against Lean Rx, Inc. dba SkinnyRx, issued February 2026
  • Brand-name drugs appear in its catalog, but the Wegovy pill is listed as unavailable

Regulatory note: the FDA issued a warning letter to Lean Rx, Inc. dba SkinnyRx in February 2026. We still list and link to SkinnyRx; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check SkinnyRx pricing Read the full SkinnyRx review

ReadyRx

Patients comparing the actual renewal cost of monthly and quarterly plans with care and shipping included.

Reasons to consider it

  • Current one-month renewal rates are $249 semaglutide and $315 tirzepatide
  • The public price calculator separates first-month discounts from renewal prices
  • Provider messaging, shipping, protocols, meal plans and coaching are included

What to weigh up

  • Headline first-month offers are lower than the recurring price
  • The lower $179 semaglutide first-month offer is calculated for the quarterly plan
  • Cancel at least four business days before renewal; shipments can be processed early

Compounded drugs are not FDA-approved. Understand the medication options.

Check ReadyRx pricing Read the full ReadyRx review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

SkinnyRxReadyRx
Normalized Cost/Month
SkinnyRx:
71/100
ReadyRx:
61/100
Price Transparency
SkinnyRx:
84/100
ReadyRx:
94/100
Nationwide Access
SkinnyRx:
82/100
ReadyRx:
86/100
Formulation Options
SkinnyRx:
73/100
ReadyRx:
79/100
Clinical Oversight
SkinnyRx:
66/100
ReadyRx:
79/100
Contract Flexibility
SkinnyRx:
58/100
ReadyRx:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to SkinnyRxAlternatives to ReadyRx
More provider matchups
CoreAge Rx vs SkinnyRxCoreAge Rx vs ReadyRx
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.